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Use of the Xpert MTB/RIF assay in the 
diagnosis of tuberculous meningitis:  
A cautionary note
To the Editor: The Xpert MTB/RIF (Cepheid) assay is a nucleic 
acid amplification test developed to detect mycobacterial tuberc­
ulosis (MTB) infection and rifampicin resistance. It is a closed 
system, requires minimal training to use, and produces a result in a 
few hours. When used as an initial diagnostic test replacing smear 
microscopy for pulmonary tuberculosis, the Xpert MTB/RIF has 
a pooled sensitivity of 88%.[1] The application of this test has been 
extended to extrapulmonary samples, including cerebrospinal fluid 
(CSF).
The World Health Organization (WHO) evaluated the results 
of 709 CSF samples tested with Xpert MTB/RIF in 16 studies 
using culture as a reference standard. Sensitivity varied widely, 
ranging from 51% to 100%.[1] Using a 3 ml volume of CSF and 
including a concentration step increased sensitivity.[1,2] The WHO 
recommends that the Xpert MTB/RIF should be the first test to 
be undertaken on CSF from patients with suspected tuberculous 
meningitis (TBM). However, caution is advised, as the following 
case illustrates.
A 43­year­old HIV­positive man was admitted to a peripheral 
hospital in South Africa with a 2­week history of headache and a 
more recent onset of slurred speech, inability to walk and impaired 
consciousness. A computed tomography scan of the brain showed 
mild hydrocephalus and basal enhancement. Lumbar puncture 
revealed an opening pressure of 4 cm H2O, yellow colour, lympho­
cytes 300/l, a protein level of 1.06 g/l and glucose level of 1.3 
mmol/l. The Xpert MTB/RIF was negative. On the basis of this 
negative test result, initiation of antituberculosis (anti­TB) therapy 
was deferred and ceftriaxone was started. The patient was referred 
to the neurology unit at Inkosi Albert Luthuli Central Hospital in 
Durban 4 days later. He was noted to have a Glagow Coma Score 
of 8/15, meningism and normal optic fundi. He could move all his 
limbs. Anti­TB drugs and steroids were commenced, but he died 
within 3 hours of admission.
Ignoring the Xpert MTB/RIF result, this patient’s clinical, 
radiological and CSF profile is consistent with probable TBM.
[3] As standard of care, he would have been started on anti­TB 
therapy and steroids while awaiting the other laboratory results. 
The WHO, understandably, based its recommendation on studies 
done in research settings, where as much as 3 ml of CSF was used 
in at least one study.[2] For busy routine laboratories the extra step of 
concentration may be burdensome, and moreover they are unlikely 
to receive such a large volume of CSF.
As this test for TBM becomes more widely available it will 
be requested at all levels of care by medical personnel who have 
varying degrees of clinical skill, knowledge and experience. Herein 
lies the concern. Clinicians need to understand that, as with other 
tests for diagnosis of TBM, the Xpert MTB/RIF is a good ‘rule­in’ 
test (i.e. specificity approaching 100%) but a poor ‘rule­out’ test 
(moderate sensitivity).[4] A negative test does not exclude TBM. 
Clinical judgement is required. Any delay in initiating therapy risks 
an unacceptable outcome for the patient. 
The Xpert MTB/RIF test should be subjected to post­WHO 
recommendation scrutiny to determine how well it performs in 
routine clinical practice for the diagnosis of TBM.
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Hydroxyethyl starches in severe burns
To the Editor: The Medicines Control Council of South Africa 
recently lifted the suspension on the use of all medicines containing 
hydroxyethyl starch (HES), with the exclusion of, among other 
contraindications, patients with severe burns. A circular from the 
KwaZulu­Natal Department of Health furthermore restricts the 
use of HES­containing products to specialist anaesthetists, advising 
the use of Gelofusine for the ‘general resuscitation of hypovolaemic 
patients in intensive care’ or for the ‘acute resuscitation of patients 
with severe, source­controlled haemorrhagic shock in theatre by a 
specialist anaesthetist’.[1]
I submit that the exclusion of severe burns from the indications for 
the use of colloids, as well as the exclusion of consultant surgeons and 
emergency specialists from those who will be allowed to prescribe 
HES­containing products, indicates little insight into the evidence 
and the clinical situation at ‘the coalface’. It may have escaped the 
attention of pharmacologists that the majority of patients with 
hypovolaemic shock are resuscitated not by anaesthetists but by 
front­line clinicians such as those mentioned above.
The initial decision to suspend the use of HES­containing 
resuscitation fluids was based on three studies, the VISEP study,[2] 
the 6S study[3] and the CHEST study.[4] As was argued by Coetzee 
et al.,[5] among others, these studies were ‘seriously flawed and do 
not apply to the perioperative and acute resuscitation period’. The 
evidence against HES in burns resuscitation is even flimsier. Both 
the 6S study and the CHEST study excluded burns patients. The 
VISEP study included 30 patients with burns, and these were the 
subject of a post hoc analysis by Béchir et al.[6] (10 years after the 
study!); this analysis concluded that the application of hyperoncotic 
HES within the first 24 hours after severe burns ‘may be associated 
with fatal outcome and should therefore be used with caution’. Not 
only does the Béchir analysis suffer from the same drawbacks as the 
initial VISEP study, but analysis of data collected 10 years previously 
made it even more suspect. This is well borne out by the fact that 
the patients in the HES group were on average over 13 years older 
and had a higher prevalence of inhalation injury (both independent 
determinants of mortality in burns) than those who were resuscitated 
with saline alone.
An increasingly recognised complication of the resuscitation 
of patients with severe burns is the development of compartment 
syndromes, including that affecting the abdomen. A recent review 
of 50 publications including 1 616 patients quoted prevalences of 
64.7 ­ 74.5% for intra­abdominal hypertension and of 4.1 ­ 16.6% for 
abdominal compartment syndrome. The mortality rate for abdominal 
compartment syndrome in patients with severe burns was 74.8%.[7] 
The development of compartment syndrome in burns patients is 
associated with total resuscitation volumes, and a reduction of the 
resuscitation volume in the Baxter (Parklands) formula from 4 to 
3 ml/kg/% total body surface area has been proposed.[8,9] Vlachou 
et al.[10] found in a small study that patients with severe burns who 
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received part of their resuscitation fluid as HES required less fluid 
and showed less interstitial oedema than those who received their 
entire fluid requirements as crystalloid solution. Others have reported 
similar results with a variety of colloids, including a lower incidence 
of renal impairment with the use of colloids.[11,12] A review of fluid 
resuscitation in patients with severe burns concluded that ‘current 
best evidence supports recommendations to reduce fluid­volume 
administration through use of colloids or hypertonic saline’, especially 
if the required volumes would exceed a ‘volume ceiling’.[13]
Although none of this provides level I evidence for the use of 
colloids or HES in early burn resuscitation, the scales are starting 
to tip in favour of the latter. Meanwhile, the evidence that HES is 
detrimental seems flimsy. Until large­scale studies are available, 
decisions to use colloids such as HES are best left to those who have 
made it their expertise to care for these complex cases.
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Professional competence – adding 
reflective elements to case reports
To the Editor: Logbooks of procedures are helpful in determining the 
professional competence of trainees. There has been corres pondence 
in the SAMJ on aspects of their use in South Africa – for example, the 
value of specifying the number of surgical operations in the logbook.[1,2]
However, experience does not automatically translate into learning. 
Reflection is needed to turn experience into learning. Logbooks of 
procedures may be complemented by case reports that are structured 
so as to contain a reflective element.
The College of Radiation Oncologists of South Africa has used 
structured case reports for the past 4 years, based on a model developed 
by the Royal Australian and New Zealand College of Radio logy. These 
structured case reports include technical aspects of cases from both the 
clinical and treatment points of view, as well as the potential benefits 
and toxicity of treatment. In addition, candidates describe both the 
lessons they have learnt and the candidate’s role in treating the case, 
to add a reflective element. A minimum of 20 structured case reports 
are produced during training, which are individually signed off and 
included in a larger learning portfolio.
The correspondence in the SAMJ does not make it clear whether 
it is practice to have the logbooks scrutinised by the examiners. It 
is appreciated that this can be logistically difficult. The College of 
Radiation Oncologists has dealt with this by having the candidates 
present their learning portfolios with structured case reports to their 
examiners one or more days before their oral examinations. The case 
reports are scrutinised, usually overnight, and the candidates then 
undergo an oral examination on the structured case reports. This is 
helpful in assessing the authenticity of the candidates’ practical and 
learning experience.
The experience with structured case reports has been helpful in 
both training and examining candidates, and the system could be 
extended and expanded.
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The ‘Marketplace’ – a novel conference 
teaching and learning model
To the Editor: The word ‘marketplace’ brings to mind a bustling, 
colourful place where shoppers come to browse goods. The range 
of items on offer may vary from week to week and from market to 
market, but is usually led by one principle: what do the shoppers 
around here want to buy? The same principle of supplying a need 
can be applied to the ‘purchase’ of knowledge at medical conferences. 
However, most conferences tend to offer solely didactic lectures 
with little opportunity for meaningful direct interaction between the 
delegates and experts/speakers.
Over the past few years, I have run a novel and highly popular teaching 
and learning event called the Paediatric Marketplace at the Emergency 
Medicine Society of South Africa conferences in Cape Town. The central 
idea is to have a dynamic, fun, interactive session based on a market­style 
environment, where delegates (shoppers) browse and chat with experts 
(stallholders), who tailor their teaching to individual needs.
Between ten and twelve market­stalls are set up on any topics of 
interest (e.g. cardiopulmonary resuscitation, triage, intraosseous line 
insertion, the ‘blue baby’, fluid management in children, cervical 
spine immobilisation, foreign body removal techniques, childhood 
poisoning, etc.). The stalls have eye­catching and inviting materials 
such as posters, interactive cases, quizzes, video material, radiology 
images, etc. Mannequins and/or equipment to demonstrate skills 
are available where appropriate. Delegates are free to browse at their 
own pace, and they will naturally stop and spend time at stalls that 
interest them.
In June this year the Paediatric Marketplace was invited to ‘go 
global’ with a large­scale event at the International Federation of 
Emergency Medicine (IFEM) Conference in Hong Kong (ICEM 
2014). Our expert stallholders were members of the IFEM Paediatric 
